First Personal Financial Services Glycomimetics Inc Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$14.63 - $19.19 $14,278 - $18,729	-976 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$16.06 - $25.35 $7,275 - $11,483	-453 Reduced 31.7%	976 $16,000
Q4 2017 Jan 25, 2018	SELL	$10.51 - $17.22 $4,866 - $7,972	-463 Reduced 24.47%	1,429 $24,000
Q3 2017 Nov 01, 2017	BUY	$10.14 - $14.85 $19,184 - $28,096	1,892	1,892 $26,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.